TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).

Manish A Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.